Earth Science Tech, Inc. (ETST) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
ETST representa a Earth Science Tech, Inc., una empresa del sector Healthcare con un precio de $ (capitalización de mercado 0). La acción obtiene una puntuación de 61/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 17 mar 2026Earth Science Tech, Inc. (ETST) Resumen de Asistencia Médica y Tuberías
Earth Science Tech, Inc. operates in the healthcare sector, focusing on nutraceuticals and dietary supplements for various health conditions. With a market capitalization of $0.03 billion and a P/E ratio of 9.88, the company distributes its products through retail, clinics, pharmacies, and online channels, competing in a fragmented market.
Tesis de Inversión
Earth Science Tech, Inc. presents a speculative investment opportunity within the nutraceutical and dietary supplement market. With a market capitalization of $0.03 billion and a P/E ratio of 9.88, the company's valuation reflects both its growth potential and inherent risks associated with OTC-listed companies. A gross margin of 65.1% indicates strong pricing power, while a profit margin of 10.0% demonstrates profitability. Growth catalysts include expanding its online presence and developing new formulations for existing products. However, potential risks include the company's reliance on a limited product line and the competitive nature of the nutraceutical market. The company's high beta of 2.02 suggests significant volatility, making it suitable for investors with a high-risk tolerance. The lack of dividend yield further emphasizes its growth-oriented profile.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $0.03 billion indicates a small-cap company with potential for growth but also higher risk.
- P/E ratio of 9.88 suggests the company is potentially undervalued compared to its earnings.
- Gross margin of 65.1% reflects strong pricing power and efficient cost management.
- Profit margin of 10.0% demonstrates the company's ability to generate profit after all expenses.
- Beta of 2.02 indicates high volatility compared to the market, suggesting higher risk and potential reward.
Competidores y Pares
Fortalezas
- Diverse product line targeting various health conditions.
- Multi-channel distribution network.
- Strong gross margin indicating pricing power.
- Focus on natural and alternative health solutions.
Debilidades
- Small market capitalization and limited financial resources.
- High beta indicating significant volatility.
- Reliance on a limited number of key products.
- Limited brand recognition compared to larger competitors.
Catalizadores
- Upcoming: Potential new product launches in the nutraceutical and dietary supplement market.
- Ongoing: Expansion of online presence and e-commerce sales channels.
- Ongoing: Strategic partnerships with clinics, pharmacies, and healthcare providers.
Riesgos
- Potential: Intense competition from larger and more established companies in the nutraceutical industry.
- Potential: Changing regulations and compliance requirements affecting the dietary supplement market.
- Potential: Fluctuations in raw material prices impacting the company's profitability.
- Ongoing: Limited financial resources and small market capitalization.
- Ongoing: High beta indicating significant price volatility.
Oportunidades de crecimiento
- Expanding Online Presence: ETST can capitalize on the growing e-commerce trend by enhancing its online platform and digital marketing efforts. The global e-commerce market is projected to reach trillions of dollars in the coming years, offering a significant opportunity for ETST to increase its sales and market reach. By investing in SEO, social media marketing, and targeted advertising, ETST can attract new customers and drive online sales, with an expected impact within the next 1-2 years.
- Developing New Formulations: ETST can invest in research and development to create new and innovative formulations for its existing products. The nutraceutical industry is constantly evolving, with new ingredients and delivery methods emerging regularly. By staying ahead of the curve and developing unique and effective formulations, ETST can differentiate itself from competitors and attract health-conscious consumers. This could lead to new product launches within the next 18-24 months.
- Strategic Partnerships: ETST can form strategic partnerships with clinics, pharmacies, and healthcare providers to expand its distribution network and reach a wider audience. Collaborating with established healthcare professionals can enhance ETST's credibility and build trust with consumers. These partnerships could be established within the next year, leading to increased sales and market penetration.
- Geographic Expansion: ETST can explore opportunities to expand its operations into new geographic markets, particularly in regions with a growing demand for nutraceuticals and dietary supplements. Emerging markets in Asia and Latin America offer significant growth potential. By conducting market research and adapting its products to local preferences, ETST can successfully enter new markets and diversify its revenue streams over the next 2-3 years.
- Focus on Specific Health Conditions: ETST can focus its marketing efforts on specific health conditions, such as chronic pain, joint pain, and inflammation. By targeting consumers with specific health needs, ETST can increase its brand awareness and build a loyal customer base. This targeted approach can be implemented within the next 6-12 months, leading to improved marketing ROI and increased sales.
Oportunidades
- Expanding online presence and e-commerce sales.
- Developing new and innovative product formulations.
- Forming strategic partnerships with healthcare providers.
- Entering new geographic markets with growing demand for nutraceuticals.
Amenazas
- Intense competition from larger and more established companies.
- Changing regulations and compliance requirements.
- Fluctuations in raw material prices.
- Negative publicity or adverse events affecting the nutraceutical industry.
Ventajas competitivas
- Proprietary formulations and unique product offerings.
- Established distribution network through multiple channels.
- Brand recognition and customer loyalty in specific market segments.
Acerca de ETST
Earth Science Tech, Inc. (ETST) is a biotechnology company that develops, markets, and distributes nutraceuticals, bioceuticals, and dietary supplements. Founded in 2010 and formerly known as Ultimate Novelty Sports, Inc., the company rebranded in March 2014 to focus on health and wellness products. Headquartered in Doral, Florida, ETST offers a range of products targeting chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. The company's product portfolio includes hemp oils, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods, and other products. These are available in various formulations such as capsules, tablets, soft gels, chewables, liquids, creams, sprays, and powders. ETST distributes its products through multiple channels, including its retail store, clinics, pharmacies, and online platforms. This multi-channel approach aims to maximize market reach and cater to diverse customer preferences. ETST also provides medical equipment and devices, further diversifying its offerings within the healthcare sector. The company operates with 32 employees and aims to expand its market presence through innovative product development and strategic distribution partnerships.
Qué hacen
- Develops and markets nutraceuticals and bioceuticals.
- Offers dietary supplements for various health conditions.
- Provides products targeting chronic pain, joint pain, and inflammation.
- Distributes hemp oils, vitamins, minerals, and herbs.
- Sells personal care products, homeopathies, and functional foods.
- Offers medical equipment and devices.
Modelo de Negocio
- Develops and manufactures nutraceutical and dietary supplement products.
- Distributes products through retail stores, clinics, pharmacies, and online channels.
- Generates revenue through the sale of its products to consumers and healthcare providers.
Contexto de la Industria
Earth Science Tech, Inc. operates within the growing nutraceutical and dietary supplement industry. This market is characterized by increasing consumer awareness of health and wellness, driving demand for natural and alternative health solutions. The industry is highly competitive, with numerous players ranging from large pharmaceutical companies to smaller, specialized firms. ETST competes with companies offering similar products, focusing on specific health conditions and distribution channels. The global nutraceutical market is expected to continue growing, driven by aging populations and rising healthcare costs.
Clientes Clave
- Individuals seeking natural health and wellness solutions.
- Patients with chronic pain, joint pain, and inflammation.
- Healthcare providers recommending supplements to their patients.
- Consumers interested in vitamins, minerals, and herbal remedies.
Finanzas
Gráfico e información
Precio de la acción de Earth Science Tech, Inc. (ETST): Price data unavailable
Últimas noticias
-
Stocks That Hit 52-Week Highs On Tuesday
· 24 mar 2020
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para ETST.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para ETST.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de ETST en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Giorgio R. Saumat
CEO
Giorgio R. Saumat serves as the Chief Executive Officer of Earth Science Tech, Inc. His background includes experience in managing and growing businesses, with a focus on strategic planning and operational efficiency. He is responsible for overseeing the company's overall strategy, product development, and market expansion efforts. His leadership aims to drive innovation and growth within the nutraceutical and dietary supplement market.
Historial: Under Giorgio R. Saumat's leadership, Earth Science Tech, Inc. has focused on expanding its product line and distribution channels. Key achievements include the development of new formulations and the establishment of strategic partnerships. His tenure has been marked by efforts to increase brand awareness and market penetration within the competitive nutraceutical industry.
Información del mercado OTC de ETST
The OTC Other tier represents the lowest tier of the OTC market, indicating that Earth Science Tech, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure and transparency.
- Lower trading volumes and liquidity.
- Greater price volatility and potential for manipulation.
- Higher risk of fraud or mismanagement.
- Limited regulatory oversight and investor protection.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's OTC Markets profile and disclosure history.
- Check for any regulatory actions or legal proceedings involving the company.
- Consult with a qualified financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- Company has been in operation since 2010.
- Company has a diverse product line targeting various health conditions.
- Company distributes products through multiple channels, including retail stores and online platforms.
Preguntas Comunes Sobre ETST
¿Cuáles son los factores clave para evaluar ETST?
Earth Science Tech, Inc. (ETST) actualmente tiene una puntuación IA de 61/100, indicando puntuación moderada. Fortaleza clave: Diverse product line targeting various health conditions.. Riesgo principal a monitorear: Potential: Intense competition from larger and more established companies in the nutraceutical industry.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de ETST?
ETST actualmente puntúa 61/100 (Grado B) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de ETST?
Los precios de ETST se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre ETST?
La cobertura de analistas para ETST incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en ETST?
Las categorías de riesgo para ETST incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Intense competition from larger and more established companies in the nutraceutical industry.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de ETST?
La relación P/E para ETST compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está ETST sobrevalorada o infravalorada?
Determinar si Earth Science Tech, Inc. (ETST) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de ETST?
Earth Science Tech, Inc. (ETST) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Information is based on available data and may be subject to change.
- OTC market data may be less reliable than data from major exchanges.